Skip to main content
Acta Crystallographica Section E: Crystallographic Communications logoLink to Acta Crystallographica Section E: Crystallographic Communications
. 2015 Sep 26;71(Pt 10):1207–1211. doi: 10.1107/S2056989015017119

Crystal structures of two chiral piperidine derivatives: 1-[(1R)-2-hy­droxy-1-phenyl­eth­yl]piperidin-4-one and 8-[(1S)-1-phenyl­eth­yl]-1,4-dioxa-8-aza­spiro­[4.5]decane-7-thione

Nancy Romero a, Sylvain Bernès b,*, Luis F Roa a, Joel L Terán c, Dino Gnecco c
PMCID: PMC4647425  PMID: 26594408

The conformation of the piperidine ring is modified by the hybridization state of the C atom in the α-position to the piperidinic N atom.

Keywords: crystal structure, piperidine, piperidone, thione, ring conformation

Abstract

The crystal structures of the two title piperidine derivatives show different conformations for the six-membered heterocycle. The N-substituted 4-piperidinone 1-[(1R)-2-hy­droxy-1-phenyl­eth­yl]piperidin-4-one, C13H17NO2, (I), has a chair conformation, while the piperidine substituted in position 2 with a thio­carbonyl group, 8-[(1S)-1-phenyl­eth­yl]-1,4-dioxa-8-aza­spiro­[4.5]decane-7-thione, C15H19NO2S, (II), features a half-chair conformation. Comparison of the two structures, and data retrieved from the literature, suggests that the conformational flexibility is mainly related to the hybridization state of the C atom α to the piperidinic N atom: a Csp 3 atom favours the chair conformer, while a Csp 2 atom distorts the ring towards a half-chair conformer. In the crystal structure of (I), weak C—H⋯O hydrogen bonds link the mol­ecules into supra­molecular chains propagating along the b-axis direction. In the crystal of (II), the mol­ecules are linked by weak C—H⋯S contacts into supra­molecular chains propagating along the b-axis direction.

Chemical context  

The 4-piperidone scaffold has been used as a building block for the synthesis of more complex heterocyclic compounds. An example is the one-pot three-step synthesis of fentanyl [N-(1-phenethyl-4-piperid­yl) propionanilide], a strong agonist of μ-opioid receptors, used for its potent analgesic activity. This industrial synthesis, patented by Janssen Pharmaceutica (Gupta et al., 2010) employs 4-piperidone hydro­chloride monohydrate as the starting material. The range of biological activity for 4-piperidone derivatives is quite broad, including anti-inflammatory, anti­cancer, anti­bacterial and anti­fungal properties. For this reason, new synthetic methods are being sought proactively in this field (e.g. Tortolani & Poss, 1999; Davis et al., 2001; Das et al., 2010). For our part, our emphasis is on the synthesis of chiral N-substituted piperidone derivatives (e.g. Romero et al., 2007).graphic file with name e-71-01207-scheme1.jpg

In this context, X-ray crystallography is a potent tool to assess the conformational modifications experienced by the piperidine heterocycle while its substitution pattern is altered along a synthetic route. The pair of structures reported here illustrates such conformational flexibility in this chemistry.

Structural commentary  

The first piperidin-4-one derivative [(I), Fig. 1] is a non-sterically hindered mol­ecule, and thus adopts the most stable chair conformation for the six-membered heterocycle. The total puckering amplitude is Q = 0.553 (3) Å, and the Cremer parameters are θ = 168.8 (3)° and φ = 171.8 (18)°. The deviation from the ideal conformation, θ = 180°, may be related to the heterocyclic nature of the ring, with short C—N bond lengths and longer C—C bond lengths, as expected. Moreover, atom C4 has a geometry consistent with its sp 2 hybridization state, while N1 is essentially tetra­hedral, with the lone pair occupying the axial position. The equatorial group substituting this N atom is rigid, as a result of its chiral character. However, the spatial orientation of this group allows the hydroxyl group to inter­act with the nitro­gen lone pair, stabilizing the observed mol­ecular conformation.

Figure 1.

Figure 1

The mol­ecular structure of (I), with displacement ellipsoids for non-H atoms at the 30% probability level.

The chair conformation for the piperidone in (I) was previously observed in related compounds based on the same heterocycle (Vijayakumar et al., 2010; Rajesh et al., 2010a , 2012). Apparently, the only significant variation allowed for this system is for the N atom, which may approach a planar–trigonal geometry (Shahani et al., 2010; Rajesh et al., 2010b ).

The chair conformation of (I) is, however, different from that observed for (II), derived from piperidine-2-thione (Fig. 2). In that case, the half-chair form is found in the crystal structure, characterized by a puckering amplitude Q = 0.513 (3) Å, and Cremer parameters θ = 127.5 (3)° and φ = 29.29 (5)° (ideal values: θ = 129.2° and φ = 30°). The N atom has a planar environment, the sum of angles about this center being 360°. This conformer is identical to one of the stable forms reported for piperidin-2-one (known as δ-valerolatcam): microwave spectroscopy indicated that for δ-valerolatcam, two conformers are stabilized in the gas phase, the half-chair form and the twist form (Kuze et al., 1999). δ-Valerolatcam is actually comparable to (II), because in both mol­ecules C4 has the same sp 3 hybridization. In (II), the spiro atom C4 is part of the 1,3-dioxolane ring. The slightly twisted half-chair conformation for this ring is common. The two rings are almost perpendicular, as reflected in the dihedral angle between their mean-planes of 76.4 (2)°.

Figure 2.

Figure 2

The mol­ecular structure of (II), with displacement ellipsoids for non-H atoms at the 30% probability level.

Effect of hybridization on ring conformation  

Since the ring conformation in (II) seems not to be related to any intra­molecular strong inter­action nor the hybridization modification from sp 2 to sp 3 at C4, it should be a consequence of the presence of the thio­carbonyl functionality at C2. This center is in a state very close to pure sp 2 hybridization. This is reflected in the bond length for the C=S group, 1.677 (3) Å, close to the mean value of 1.669 Å computed from almost 10000 thio­carbonyl bonds retrieved from the organics subset of the CSD (Version 5.36 with all updates; Groom & Allen, 2014. The restriction to sp 2-C centers is applied by requiring the C atom to be linked to exactly three atoms and the S atom to be linked to exactly one atom). Indeed, long C=S bonds, above 1.75 Å, are found in compounds including mol­ecules having a propensity to form hydrogen bonds, like thio­urea (Weber, 1984), thio­urea derivatives (Busschaert et al., 2011; Chumakov et al., 2006), and tri­thio­carbonic acid (Krebs & Gattow, 1965), among others. In the case of a single C—S bond based on a sp 3-hybridized C atom, the bond length is sharply distributed around 1.81 Å.

The other factor contributing to the ring conformation in (II) is the absence of the hydroxyl group in the chiral moiety, making the heterocyclic N atom inert towards potential inter­actions. The lone pair should thus be oriented randomly above and below the piperidine mean plane, through nitro­gen inversion, characterized by a low energy barrier in the gas and solution phases. Both features, the planar N atom and the neighboring sp 2-C atom, generate the half-chair conformation observed for the piperidine-2-thione core. In the present case, it is difficult to determine whether one feature dominates, or both are of importance for stabilizing the half-chair conformation. However, for the 25 hits corresponding to piperidine-2-ones deposited in the CSD, 21 of them present the same conformation as in (II), with C4 as the flap atom for the half-chair. In three cases, the puckering amplitude of the half-chair is close to 0 Å (Woydt et al., 1991; Bolla et al., 2014), and in one case, the ring presents a twist-boat conformation (Sanfilippo et al., 1992). In contrast, piperidine derivatives are stabilized almost universally in the chair conformation, with very few exceptions in some disordered structures (Thirumaran et al., 2009). These rules hold regardless of the substituent on the N atom. Applying these general rules to compounds (I) and (II), we thus infer that the ring conformation is mainly determined by the hybridization state of the C atom in position α to the piperidinic N atom.

Supra­molecular features  

In the crystal of (I), weak C—H⋯O hydrogen bonds link the mol­ecules into supra­molecular chains propagating along the b-axis direction (Table 1).

Table 1. Hydrogen-bond geometry (Å, °) for (I) .

D—H⋯A D—H H⋯A DA D—H⋯A
C3—H3A⋯O1i 0.97 2.49 3.246 (4) 135

Symmetry code: (i) Inline graphic.

The crystal structure of (II) is based on weak inter­molecular C—H⋯S contacts involving one methyl­ene group of the dioxolane ring and the thio­carbonyl functionality (Table 2), which forms chains along the 21 symmetry axis parallel to [010].

Table 2. Hydrogen-bond geometry (Å, °) for (II) .

D—H⋯A D—H H⋯A DA D—H⋯A
C16—H16B⋯S1i 0.97 2.85 3.709 (5) 148

Symmetry code: (i) Inline graphic.

Synthesis and crystallization  

Compound (I). The synthesis is illustrated in Fig. 3. A solution of compound (1), (R)-(−)-2-phenyl­glycinol (5.65 g, 41.2 mmol) with an excess of ethyl acrylate in methanol (60 mL), was stirred overnight at 298 K. The reaction mixture was concentrated, and the crude purified by column chromatography (SiO2, CH2Cl2:MeOH, 97:3), to afford (2) as a colorless oil (98%). An amount of (2) (40.6 mmol) was added to a mixture of MeONa in anh. benzene. After refluxing the mixture for 5 h, a solid was obtained, which was filtered and dried in air. This solid was treated with AcOH:water (30%, v/v) until pH = 1, initiating the deca­rboxylation process. The mixture was refluxed until gas evolution stopped. After cooling down to 298 K, pH was adjusted to 7 with NaHCO3, and the mixture was washed with CH2Cl2 (3 × 50 ml). The organic phase was dried over Na2SO4, and concentrated. Compound (I) was purified by column chromatography (SiO2, CH2Cl2:MeOH, 95:5). Compound (I) was obtained in 80% yield, and was recrystallized from an AcOEt:n-hexane mixture (1:1).

Figure 3.

Figure 3

Synthesis of (I). Reaction conditions: (i) ethyl acrylate, MeOH, 298 K, 12 h; (ii) Na/MeOH, benzene, reflux, 5 h; (iii) AcOH/H2O (30% v/v), reflux.

Compound (II). The synthesis is illustrated in Fig. 4. The synthesis of compound (3), (S)-(−)-phenyl­ethyl­piperi-2,4-dione, has been reported previously (Romero et al., 2013; see compound 5 in Fig. 1 of this report). To a solution of (3) in 50 mL of dry benzene, was added ethyl­ene glycol (0.2 mL, 3.4 mmol) and a catalytic amount of p-TSA. The mixture was refluxed until water formation, collected with a Dean–Stark trap, stopped. Then, the reaction mixture was cooled down to room temperature, treated with brine, and washed with CH2Cl2 (3 × 50 mL). The organic phase was dried over Na2SO4, and then concentrated under reduced pressure. The crude reaction was purified by column chromatography (SiO2, AcOEt:petroleum benzine), to afford compound (4) as a white oil, in 95% yield. Next, a suspension of Lawesson’s reagent (0.234 g, 0.578 mmol) in dry toluene (60 mL) was refluxed until complete dissolution of the reagent. The solution was cooled to 313 K, and a solution of (4) in anh. toluene (0.151 g, 0.578 mmol, 20 mL) was added (Romero et al., 2007). The reaction mixture was stirred for 1 h to give (II) in 90% yield, after purification by column chromatography (SiO2, petroleum ether:dicloro­methane). The product was recrystallized from CH2Cl2:n-hexane (1:1).

Figure 4.

Figure 4

Synthesis of (II). Reaction conditions: (i) ethyl­ene glycol, p-TSA, anhydrous benzene, reflux, 4 h; (ii) Lawesson’s reagent in anhydrous toluene, 313 K, 1 h.

Refinement  

Crystal data, data collection and structure refinement details are summarized in Table 3. All C-bound H atoms were placed in calculated positions, and refined as riding on their carrier atoms, and with C—H bond lengths fixed at 0.93 (aromatic CH), 0.96 (methyl CH3), 0.97 (methyl­ene CH2), or 0.98 Å (methine CH). For (I), the hydroxyl H atom, H2, was first found in a difference map. Its position was fixed in the last least-squares cycles, with O2—H2 = 0.91 Å. For all H atoms, the isotropic displacement parameters were calculated as U iso(H) = xU eq(carrier atom), where x = 1.5 for methyl and hydroxyl H atoms, and x = 1.2 otherwise. The absolute configuration for chiral centers C7 in (I) and (II) was assumed from the chirality of starting materials used for the synthesis (see previous section). In the case of (II), which contains one site producing anomalous scattering, the expected enanti­omer was confirmed by the refinement of the Flack parameter (Parsons et al., 2013).

Table 3. Experimental details.

  (I) (II)
Crystal data
Chemical formula C13H17NO2 C15H19NO2S
M r 219.27 277.37
Crystal system, space group Monoclinic, P21 Orthorhombic, P212121
Temperature (K) 296 296
a, b, c (Å) 9.7590 (11), 6.8952 (10), 9.7980 (14) 5.9731 (13), 14.948 (3), 16.127 (3)
α, β, γ (°) 90, 114.348 (9), 90 90, 90, 90
V3) 600.67 (15) 1439.9 (5)
Z 2 4
Radiation type Mo Kα Mo Kα
μ (mm−1) 0.08 0.22
Crystal size (mm) 0.60 × 0.17 × 0.12 0.60 × 0.38 × 0.36
 
Data collection
Diffractometer Bruker P4 Bruker P4 diffractometer
Absorption correction ψ scan (XSCANS; Fait, 1996)
T min, T max 0.760, 0.922
No. of measured, independent and observed [I > 2σ(I)] reflections 2700, 1341, 1050 3886, 2631, 2007
R int 0.021 0.029
(sin θ/λ)max−1) 0.595 0.650
 
Refinement
R[F 2 > 2σ(F 2)], wR(F 2), S 0.036, 0.083, 1.04 0.044, 0.120, 1.06
No. of reflections 1341 2631
No. of parameters 146 174
No. of restraints 1 0
H-atom treatment H-atom parameters constrained H-atom parameters constrained
Δρmax, Δρmin (e Å−3) 0.11, −0.11 0.19, −0.24
Absolute structure Assigned from the synthesis Flack x determined using 483 quotients [(I +)−(I )]/[(I +)+(I )] (Parsons et al., 2013)
Absolute structure parameter 0.08 (7)

Computer programs: XSCANS (Fait, 1996), SHELXS97 and SHELXTL (Sheldrick, 2008) and SHELXL2014 (Sheldrick, 2015).

Supplementary Material

Crystal structure: contains datablock(s) I, II, global. DOI: 10.1107/S2056989015017119/xu5868sup1.cif

e-71-01207-sup1.cif (229.4KB, cif)

Structure factors: contains datablock(s) I. DOI: 10.1107/S2056989015017119/xu5868Isup2.hkl

e-71-01207-Isup2.hkl (108.5KB, hkl)

Structure factors: contains datablock(s) II. DOI: 10.1107/S2056989015017119/xu5868IIsup3.hkl

e-71-01207-IIsup3.hkl (210.6KB, hkl)

Supporting information file. DOI: 10.1107/S2056989015017119/xu5868Isup4.cml

Supporting information file. DOI: 10.1107/S2056989015017119/xu5868IIsup5.cml

CCDC references: 1424094, 1424093

Additional supporting information: crystallographic information; 3D view; checkCIF report

Acknowledgments

The authors thank the ‘Programa de Fortalecimiento a la Investigación’ of the Universidad Juárez Autónoma de Tabasco for financial support via the project UJAT-2013-IB-13.

supplementary crystallographic information

(I) 1-[(1R)-2-Hydroxy-1-phenylethyl]piperidin-4-one . Crystal data

C13H17NO2 F(000) = 236
Mr = 219.27 Dx = 1.212 Mg m3
Monoclinic, P21 Mo Kα radiation, λ = 0.71073 Å
a = 9.7590 (11) Å Cell parameters from 53 reflections
b = 6.8952 (10) Å θ = 3.7–11.1°
c = 9.7980 (14) Å µ = 0.08 mm1
β = 114.348 (9)° T = 296 K
V = 600.67 (15) Å3 Plate, pale yellow
Z = 2 0.60 × 0.17 × 0.12 mm

(I) 1-[(1R)-2-Hydroxy-1-phenylethyl]piperidin-4-one . Data collection

Bruker P4 diffractometer Rint = 0.021
Radiation source: fine-focus sealed tube θmax = 25.0°, θmin = 2.3°
Graphite monochromator h = −11→4
2θ/ω scans k = −1→8
2700 measured reflections l = −10→11
1341 independent reflections 3 standard reflections every 97 reflections
1050 reflections with I > 2σ(I) intensity decay: 0.5%

(I) 1-[(1R)-2-Hydroxy-1-phenylethyl]piperidin-4-one . Refinement

Refinement on F2 Secondary atom site location: difference Fourier map
Least-squares matrix: full Hydrogen site location: inferred from neighbouring sites
R[F2 > 2σ(F2)] = 0.036 H-atom parameters constrained
wR(F2) = 0.083 w = 1/[σ2(Fo2) + (0.0372P)2 + 0.0246P] where P = (Fo2 + 2Fc2)/3
S = 1.04 (Δ/σ)max < 0.001
1341 reflections Δρmax = 0.11 e Å3
146 parameters Δρmin = −0.11 e Å3
1 restraint Extinction correction: SHELXL2014 (Sheldrick, 2015), Fc*=kFc[1+0.001xFc2λ3/sin(2θ)]-1/4
0 constraints Extinction coefficient: 0.040 (6)
Primary atom site location: structure-invariant direct methods Absolute structure: Assigned from the synthesis

(I) 1-[(1R)-2-Hydroxy-1-phenylethyl]piperidin-4-one . Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2)

x y z Uiso*/Ueq
N1 0.8276 (2) 0.3211 (3) 0.1078 (2) 0.0427 (5)
O1 0.9225 (3) 0.7423 (5) 0.4197 (3) 0.1214 (11)
O2 0.7952 (2) −0.0767 (3) 0.0760 (3) 0.0797 (7)
H2 0.8389 0.0052 0.1543 0.120*
C2 0.9480 (3) 0.4619 (4) 0.1324 (3) 0.0502 (7)
H2B 0.9068 0.5750 0.0700 0.060*
H2C 1.0229 0.4047 0.1036 0.060*
C3 1.0222 (3) 0.5237 (5) 0.2969 (3) 0.0629 (9)
H3A 1.0773 0.4150 0.3575 0.075*
H3B 1.0934 0.6273 0.3082 0.075*
C4 0.9084 (4) 0.5914 (6) 0.3506 (3) 0.0708 (10)
C5 0.7746 (3) 0.4646 (5) 0.3102 (3) 0.0613 (9)
H5A 0.6983 0.5313 0.3318 0.074*
H5B 0.8025 0.3476 0.3705 0.074*
C6 0.7102 (3) 0.4101 (4) 0.1448 (2) 0.0491 (7)
H6A 0.6277 0.3196 0.1226 0.059*
H6B 0.6716 0.5252 0.0840 0.059*
C7 0.7704 (3) 0.2371 (4) −0.0447 (3) 0.0461 (7)
H7A 0.8596 0.2074 −0.0631 0.055*
C8 0.6978 (3) 0.0421 (4) −0.0420 (3) 0.0626 (8)
H8A 0.6054 0.0634 −0.0296 0.075*
H8B 0.6726 −0.0237 −0.1368 0.075*
C9 0.6741 (3) 0.3692 (4) −0.1714 (2) 0.0460 (7)
C10 0.7397 (3) 0.4820 (5) −0.2455 (3) 0.0570 (8)
H10A 0.8428 0.4733 −0.2180 0.068*
C11 0.6544 (4) 0.6079 (6) −0.3602 (3) 0.0737 (9)
H11A 0.7010 0.6837 −0.4072 0.088*
C12 0.5013 (4) 0.6203 (6) −0.4042 (3) 0.0786 (10)
H12A 0.4440 0.7028 −0.4819 0.094*
C13 0.4338 (4) 0.5101 (5) −0.3326 (3) 0.0684 (9)
H13A 0.3304 0.5181 −0.3620 0.082*
C14 0.5188 (3) 0.3872 (4) −0.2169 (3) 0.0541 (7)
H14A 0.4716 0.3151 −0.1684 0.065*

(I) 1-[(1R)-2-Hydroxy-1-phenylethyl]piperidin-4-one . Atomic displacement parameters (Å2)

U11 U22 U33 U12 U13 U23
N1 0.0361 (11) 0.0413 (12) 0.0519 (12) 0.0012 (11) 0.0192 (9) 0.0002 (11)
O1 0.130 (2) 0.119 (2) 0.104 (2) −0.022 (2) 0.0365 (16) −0.062 (2)
O2 0.0924 (15) 0.0412 (12) 0.1027 (14) 0.0085 (13) 0.0374 (12) 0.0124 (13)
C2 0.0445 (14) 0.0492 (17) 0.0558 (14) −0.0064 (15) 0.0194 (11) 0.0027 (14)
C3 0.0533 (16) 0.068 (2) 0.0566 (15) −0.0138 (18) 0.0114 (13) 0.0026 (17)
C4 0.080 (2) 0.077 (3) 0.0418 (14) 0.003 (2) 0.0114 (15) −0.0097 (18)
C5 0.0580 (16) 0.080 (2) 0.0481 (14) 0.0064 (19) 0.0243 (13) −0.0025 (17)
C6 0.0442 (13) 0.0563 (18) 0.0487 (13) 0.0012 (16) 0.0210 (11) −0.0009 (15)
C7 0.0480 (14) 0.0403 (14) 0.0555 (15) 0.0030 (14) 0.0270 (12) −0.0042 (14)
C8 0.0660 (19) 0.0403 (16) 0.0795 (19) −0.0022 (16) 0.0281 (16) −0.0061 (16)
C9 0.0559 (15) 0.0404 (17) 0.0435 (13) −0.0022 (15) 0.0222 (12) −0.0068 (14)
C10 0.0677 (17) 0.0555 (18) 0.0520 (15) −0.0106 (17) 0.0287 (14) −0.0061 (16)
C11 0.104 (3) 0.061 (2) 0.0584 (17) −0.011 (2) 0.0357 (18) 0.0015 (19)
C12 0.101 (3) 0.065 (2) 0.0548 (17) 0.008 (2) 0.0177 (19) 0.0020 (19)
C13 0.0633 (18) 0.071 (2) 0.0594 (17) 0.0094 (19) 0.0132 (15) −0.0004 (18)
C14 0.0546 (15) 0.0540 (19) 0.0515 (14) −0.0038 (16) 0.0195 (13) −0.0051 (15)

(I) 1-[(1R)-2-Hydroxy-1-phenylethyl]piperidin-4-one . Geometric parameters (Å, º)

N1—C2 1.466 (3) C6—H6B 0.9700
N1—C6 1.469 (3) C7—C9 1.514 (4)
N1—C7 1.481 (3) C7—C8 1.525 (4)
O1—C4 1.217 (4) C7—H7A 0.9800
O2—C8 1.416 (3) C8—H8A 0.9700
O2—H2 0.9051 C8—H8B 0.9700
C2—C3 1.530 (4) C9—C10 1.387 (4)
C2—H2B 0.9700 C9—C14 1.398 (3)
C2—H2C 0.9700 C10—C11 1.392 (5)
C3—C4 1.487 (5) C10—H10A 0.9300
C3—H3A 0.9700 C11—C12 1.376 (4)
C3—H3B 0.9700 C11—H11A 0.9300
C4—C5 1.483 (5) C12—C13 1.373 (5)
C5—C6 1.524 (3) C12—H12A 0.9300
C5—H5A 0.9700 C13—C14 1.385 (4)
C5—H5B 0.9700 C13—H13A 0.9300
C6—H6A 0.9700 C14—H14A 0.9300
C2—N1—C6 109.7 (2) N1—C7—C9 116.1 (2)
C2—N1—C7 111.57 (19) N1—C7—C8 108.1 (2)
C6—N1—C7 113.85 (17) C9—C7—C8 114.2 (2)
C8—O2—H2 104.7 N1—C7—H7A 105.9
N1—C2—C3 110.9 (2) C9—C7—H7A 105.9
N1—C2—H2B 109.5 C8—C7—H7A 105.9
C3—C2—H2B 109.5 O2—C8—C7 111.4 (2)
N1—C2—H2C 109.5 O2—C8—H8A 109.4
C3—C2—H2C 109.5 C7—C8—H8A 109.4
H2B—C2—H2C 108.0 O2—C8—H8B 109.4
C4—C3—C2 111.2 (2) C7—C8—H8B 109.4
C4—C3—H3A 109.4 H8A—C8—H8B 108.0
C2—C3—H3A 109.4 C10—C9—C14 117.2 (2)
C4—C3—H3B 109.4 C10—C9—C7 120.1 (2)
C2—C3—H3B 109.4 C14—C9—C7 122.7 (2)
H3A—C3—H3B 108.0 C9—C10—C11 121.4 (3)
O1—C4—C5 122.6 (3) C9—C10—H10A 119.3
O1—C4—C3 122.3 (4) C11—C10—H10A 119.3
C5—C4—C3 115.1 (3) C12—C11—C10 120.2 (3)
C4—C5—C6 111.1 (2) C12—C11—H11A 119.9
C4—C5—H5A 109.4 C10—C11—H11A 119.9
C6—C5—H5A 109.4 C13—C12—C11 119.5 (3)
C4—C5—H5B 109.4 C13—C12—H12A 120.2
C6—C5—H5B 109.4 C11—C12—H12A 120.2
H5A—C5—H5B 108.0 C12—C13—C14 120.4 (3)
N1—C6—C5 110.09 (19) C12—C13—H13A 119.8
N1—C6—H6A 109.6 C14—C13—H13A 119.8
C5—C6—H6A 109.6 C13—C14—C9 121.4 (3)
N1—C6—H6B 109.6 C13—C14—H14A 119.3
C5—C6—H6B 109.6 C9—C14—H14A 119.3
H6A—C6—H6B 108.2
C6—N1—C2—C3 61.7 (3) N1—C7—C8—O2 −50.9 (3)
C7—N1—C2—C3 −171.2 (2) C9—C7—C8—O2 178.2 (2)
N1—C2—C3—C4 −52.6 (4) N1—C7—C9—C10 91.9 (3)
C2—C3—C4—O1 −131.9 (3) C8—C7—C9—C10 −141.3 (2)
C2—C3—C4—C5 46.5 (4) N1—C7—C9—C14 −86.8 (3)
O1—C4—C5—C6 130.5 (3) C8—C7—C9—C14 40.1 (3)
C3—C4—C5—C6 −47.9 (4) C14—C9—C10—C11 0.1 (4)
C2—N1—C6—C5 −62.8 (3) C7—C9—C10—C11 −178.6 (3)
C7—N1—C6—C5 171.4 (2) C9—C10—C11—C12 −1.1 (5)
C4—C5—C6—N1 55.1 (4) C10—C11—C12—C13 1.0 (5)
C2—N1—C7—C9 −73.2 (3) C11—C12—C13—C14 0.0 (5)
C6—N1—C7—C9 51.5 (3) C12—C13—C14—C9 −1.0 (5)
C2—N1—C7—C8 157.0 (2) C10—C9—C14—C13 1.0 (4)
C6—N1—C7—C8 −78.3 (3) C7—C9—C14—C13 179.6 (3)

(I) 1-[(1R)-2-Hydroxy-1-phenylethyl]piperidin-4-one . Hydrogen-bond geometry (Å, º)

D—H···A D—H H···A D···A D—H···A
O2—H2···N1 0.91 2.22 2.764 (3) 118
C2—H2B···O2i 0.97 2.65 3.460 (4) 142
C3—H3A···O1ii 0.97 2.49 3.246 (4) 135

Symmetry codes: (i) x, y+1, z; (ii) −x+2, y−1/2, −z+1.

(II) 8-[(1S)-1-Phenylethyl]-1,4-dioxa-8-azaspiro[4.5]decane-7-thione . Crystal data

C15H19NO2S Dx = 1.279 Mg m3
Mr = 277.37 Mo Kα radiation, λ = 0.71073 Å
Orthorhombic, P212121 Cell parameters from 58 reflections
a = 5.9731 (13) Å θ = 4.7–12.5°
b = 14.948 (3) Å µ = 0.22 mm1
c = 16.127 (3) Å T = 296 K
V = 1439.9 (5) Å3 Irregular, colourless
Z = 4 0.60 × 0.38 × 0.36 mm
F(000) = 592

(II) 8-[(1S)-1-Phenylethyl]-1,4-dioxa-8-azaspiro[4.5]decane-7-thione . Data collection

Bruker P4 diffractometer 2007 reflections with I > 2σ(I)
Radiation source: fine-focus sealed tube Rint = 0.029
Graphite monochromator θmax = 27.5°, θmin = 1.9°
2θ/ω scans h = −7→3
Absorption correction: ψ scan (XSCANS; Fait, 1996) k = −19→19
Tmin = 0.760, Tmax = 0.922 l = −20→20
3886 measured reflections 3 standard reflections every 97 reflections
2631 independent reflections intensity decay: 1.5%

(II) 8-[(1S)-1-Phenylethyl]-1,4-dioxa-8-azaspiro[4.5]decane-7-thione . Refinement

Refinement on F2 Hydrogen site location: inferred from neighbouring sites
Least-squares matrix: full H-atom parameters constrained
R[F2 > 2σ(F2)] = 0.044 w = 1/[σ2(Fo2) + (0.0668P)2 + 0.0631P] where P = (Fo2 + 2Fc2)/3
wR(F2) = 0.120 (Δ/σ)max < 0.001
S = 1.06 Δρmax = 0.19 e Å3
2631 reflections Δρmin = −0.24 e Å3
174 parameters Extinction correction: SHELXL2014 (Sheldrick, 2015), Fc*=kFc[1+0.001xFc2λ3/sin(2θ)]-1/4
0 restraints Extinction coefficient: 0.014 (4)
0 constraints Absolute structure: Flack x determined using 483 quotients [(I+)-(I-)]/[(I+)+(I-)] (Parsons et al., 2013)
Primary atom site location: structure-invariant direct methods Absolute structure parameter: 0.08 (7)
Secondary atom site location: difference Fourier map

(II) 8-[(1S)-1-Phenylethyl]-1,4-dioxa-8-azaspiro[4.5]decane-7-thione . Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2)

x y z Uiso*/Ueq
S1 0.90206 (18) 0.38336 (6) 0.64284 (6) 0.0676 (3)
N1 0.5705 (4) 0.49810 (13) 0.61607 (13) 0.0409 (6)
C2 0.7114 (5) 0.46066 (19) 0.66903 (18) 0.0435 (7)
C3 0.6996 (6) 0.4875 (2) 0.75975 (18) 0.0522 (8)
H3A 0.6350 0.4383 0.7909 0.063*
H3B 0.8509 0.4964 0.7800 0.063*
C4 0.5660 (6) 0.57054 (18) 0.77730 (17) 0.0459 (7)
C5 0.3483 (6) 0.5637 (2) 0.73219 (19) 0.0532 (8)
H5A 0.2547 0.6147 0.7456 0.064*
H5B 0.2702 0.5098 0.7490 0.064*
C6 0.3927 (6) 0.5612 (2) 0.63970 (17) 0.0564 (8)
H6A 0.2557 0.5447 0.6113 0.068*
H6B 0.4342 0.6207 0.6213 0.068*
C7 0.5849 (6) 0.47717 (17) 0.52588 (16) 0.0454 (7)
H7A 0.7363 0.4545 0.5156 0.054*
C8 0.4240 (8) 0.40247 (19) 0.5035 (2) 0.0663 (10)
H8A 0.4611 0.3498 0.5346 0.099*
H8B 0.4353 0.3898 0.4453 0.099*
H8C 0.2738 0.4205 0.5164 0.099*
C9 0.5595 (6) 0.56255 (18) 0.47498 (16) 0.0434 (7)
C10 0.3737 (6) 0.5799 (2) 0.42688 (18) 0.0525 (8)
H10A 0.2566 0.5390 0.4250 0.063*
C11 0.3612 (8) 0.6593 (2) 0.38083 (18) 0.0635 (10)
H11A 0.2348 0.6712 0.3490 0.076*
C12 0.5336 (8) 0.7192 (2) 0.3824 (2) 0.0689 (11)
H12A 0.5256 0.7714 0.3512 0.083*
C13 0.7186 (8) 0.7023 (2) 0.4302 (2) 0.0684 (11)
H13A 0.8356 0.7433 0.4319 0.082*
C14 0.7310 (6) 0.6238 (2) 0.4760 (2) 0.0559 (8)
H14A 0.8576 0.6125 0.5079 0.067*
O15 0.6883 (5) 0.64740 (15) 0.75095 (14) 0.0743 (8)
C16 0.6637 (12) 0.7128 (3) 0.8120 (3) 0.120 (2)
H16A 0.5799 0.7632 0.7902 0.144*
H16B 0.8095 0.7341 0.8297 0.144*
C17 0.5447 (8) 0.6734 (2) 0.8821 (2) 0.0666 (11)
H17A 0.6241 0.6845 0.9335 0.080*
H17B 0.3948 0.6979 0.8865 0.080*
O18 0.5371 (4) 0.57972 (13) 0.86428 (12) 0.0553 (6)

(II) 8-[(1S)-1-Phenylethyl]-1,4-dioxa-8-azaspiro[4.5]decane-7-thione . Atomic displacement parameters (Å2)

U11 U22 U33 U12 U13 U23
S1 0.0725 (6) 0.0688 (6) 0.0615 (5) 0.0339 (5) −0.0020 (5) −0.0005 (4)
N1 0.0465 (14) 0.0369 (11) 0.0393 (11) 0.0038 (12) 0.0012 (12) 0.0018 (10)
C2 0.0438 (16) 0.0412 (14) 0.0456 (15) 0.0002 (14) −0.0005 (14) 0.0061 (12)
C3 0.0563 (19) 0.0588 (18) 0.0414 (15) 0.0078 (18) −0.0023 (15) 0.0039 (14)
C4 0.0578 (19) 0.0404 (14) 0.0393 (13) −0.0059 (16) 0.0102 (15) 0.0043 (12)
C5 0.054 (2) 0.0551 (17) 0.0501 (16) 0.0096 (17) 0.0064 (16) 0.0031 (14)
C6 0.065 (2) 0.0605 (18) 0.0440 (15) 0.0239 (18) 0.0021 (18) 0.0016 (14)
C7 0.0583 (19) 0.0392 (13) 0.0386 (13) 0.0007 (16) 0.0001 (16) 0.0003 (11)
C8 0.093 (3) 0.0462 (17) 0.0593 (18) −0.013 (2) −0.008 (2) 0.0002 (13)
C9 0.0552 (19) 0.0385 (13) 0.0365 (12) 0.0012 (15) 0.0025 (14) −0.0025 (11)
C10 0.059 (2) 0.0548 (16) 0.0431 (14) −0.0025 (17) −0.0062 (17) 0.0039 (13)
C11 0.074 (3) 0.071 (2) 0.0461 (16) 0.010 (2) −0.0115 (18) 0.0122 (16)
C12 0.099 (3) 0.0540 (18) 0.0543 (17) 0.003 (2) 0.008 (2) 0.0160 (16)
C13 0.084 (3) 0.0496 (19) 0.072 (2) −0.015 (2) 0.003 (2) 0.0105 (16)
C14 0.0551 (19) 0.0547 (18) 0.0580 (18) −0.0086 (18) −0.0075 (17) 0.0077 (16)
O15 0.108 (2) 0.0544 (12) 0.0601 (13) −0.0289 (14) 0.0275 (15) −0.0022 (11)
C16 0.200 (7) 0.062 (2) 0.097 (3) −0.060 (4) 0.057 (4) −0.022 (2)
C17 0.100 (3) 0.0484 (17) 0.0516 (17) −0.005 (2) 0.006 (2) −0.0045 (14)
O18 0.0793 (17) 0.0454 (10) 0.0412 (10) −0.0079 (12) 0.0118 (11) 0.0009 (8)

(II) 8-[(1S)-1-Phenylethyl]-1,4-dioxa-8-azaspiro[4.5]decane-7-thione . Geometric parameters (Å, º)

S1—C2 1.677 (3) C8—H8B 0.9600
N1—C2 1.323 (4) C8—H8C 0.9600
N1—C6 1.471 (4) C9—C14 1.375 (5)
N1—C7 1.490 (3) C9—C10 1.379 (5)
C2—C3 1.519 (4) C10—C11 1.402 (4)
C3—C4 1.503 (4) C10—H10A 0.9300
C3—H3A 0.9700 C11—C12 1.365 (6)
C3—H3B 0.9700 C11—H11A 0.9300
C4—O18 1.420 (3) C12—C13 1.370 (6)
C4—O15 1.426 (3) C12—H12A 0.9300
C4—C5 1.493 (5) C13—C14 1.388 (5)
C5—C6 1.515 (4) C13—H13A 0.9300
C5—H5A 0.9700 C14—H14A 0.9300
C5—H5B 0.9700 O15—C16 1.395 (4)
C6—H6A 0.9700 C16—C17 1.459 (5)
C6—H6B 0.9700 C16—H16A 0.9700
C7—C8 1.517 (4) C16—H16B 0.9700
C7—C9 1.525 (4) C17—O18 1.430 (3)
C7—H7A 0.9800 C17—H17A 0.9700
C8—H8A 0.9600 C17—H17B 0.9700
C2—N1—C6 124.3 (2) C7—C8—H8B 109.5
C2—N1—C7 120.3 (3) H8A—C8—H8B 109.5
C6—N1—C7 115.4 (2) C7—C8—H8C 109.5
N1—C2—C3 118.7 (3) H8A—C8—H8C 109.5
N1—C2—S1 124.1 (2) H8B—C8—H8C 109.5
C3—C2—S1 117.1 (2) C14—C9—C10 118.8 (3)
C4—C3—C2 115.1 (2) C14—C9—C7 118.5 (3)
C4—C3—H3A 108.5 C10—C9—C7 122.7 (3)
C2—C3—H3A 108.5 C9—C10—C11 120.0 (3)
C4—C3—H3B 108.5 C9—C10—H10A 120.0
C2—C3—H3B 108.5 C11—C10—H10A 120.0
H3A—C3—H3B 107.5 C12—C11—C10 120.3 (4)
O18—C4—O15 106.2 (2) C12—C11—H11A 119.8
O18—C4—C5 112.5 (3) C10—C11—H11A 119.8
O15—C4—C5 110.8 (3) C11—C12—C13 119.9 (3)
O18—C4—C3 109.3 (2) C11—C12—H12A 120.0
O15—C4—C3 109.7 (3) C13—C12—H12A 120.0
C5—C4—C3 108.3 (3) C12—C13—C14 119.8 (4)
C4—C5—C6 109.2 (3) C12—C13—H13A 120.1
C4—C5—H5A 109.8 C14—C13—H13A 120.1
C6—C5—H5A 109.8 C9—C14—C13 121.1 (3)
C4—C5—H5B 109.8 C9—C14—H14A 119.4
C6—C5—H5B 109.8 C13—C14—H14A 119.4
H5A—C5—H5B 108.3 C16—O15—C4 107.5 (3)
N1—C6—C5 113.4 (2) O15—C16—C17 108.3 (3)
N1—C6—H6A 108.9 O15—C16—H16A 110.0
C5—C6—H6A 108.9 C17—C16—H16A 110.0
N1—C6—H6B 108.9 O15—C16—H16B 110.0
C5—C6—H6B 108.9 C17—C16—H16B 110.0
H6A—C6—H6B 107.7 H16A—C16—H16B 108.4
N1—C7—C8 110.5 (3) O18—C17—C16 104.8 (3)
N1—C7—C9 110.1 (2) O18—C17—H17A 110.8
C8—C7—C9 115.2 (3) C16—C17—H17A 110.8
N1—C7—H7A 106.9 O18—C17—H17B 110.8
C8—C7—H7A 106.9 C16—C17—H17B 110.8
C9—C7—H7A 106.9 H17A—C17—H17B 108.9
C7—C8—H8A 109.5 C4—O18—C17 106.8 (2)
C6—N1—C2—C3 −3.5 (4) C8—C7—C9—C14 −163.6 (3)
C7—N1—C2—C3 176.7 (3) N1—C7—C9—C10 −110.5 (3)
C6—N1—C2—S1 175.5 (2) C8—C7—C9—C10 15.2 (4)
C7—N1—C2—S1 −4.3 (4) C14—C9—C10—C11 −0.6 (5)
N1—C2—C3—C4 −14.3 (4) C7—C9—C10—C11 −179.4 (3)
S1—C2—C3—C4 166.7 (2) C9—C10—C11—C12 0.9 (5)
C2—C3—C4—O18 170.4 (3) C10—C11—C12—C13 −0.9 (6)
C2—C3—C4—O15 −73.6 (4) C11—C12—C13—C14 0.8 (6)
C2—C3—C4—C5 47.6 (4) C10—C9—C14—C13 0.5 (5)
O18—C4—C5—C6 175.7 (2) C7—C9—C14—C13 179.3 (3)
O15—C4—C5—C6 57.1 (3) C12—C13—C14—C9 −0.5 (5)
C3—C4—C5—C6 −63.4 (3) O18—C4—O15—C16 −19.9 (5)
C2—N1—C6—C5 −13.5 (4) C5—C4—O15—C16 102.5 (4)
C7—N1—C6—C5 166.3 (3) C3—C4—O15—C16 −137.9 (4)
C4—C5—C6—N1 47.2 (4) C4—O15—C16—C17 6.2 (6)
C2—N1—C7—C8 94.8 (4) O15—C16—C17—O18 9.6 (6)
C6—N1—C7—C8 −85.0 (3) O15—C4—O18—C17 26.1 (4)
C2—N1—C7—C9 −136.8 (3) C5—C4—O18—C17 −95.3 (3)
C6—N1—C7—C9 43.4 (4) C3—C4—O18—C17 144.4 (3)
N1—C7—C9—C14 70.7 (4) C16—C17—O18—C4 −21.9 (5)

(II) 8-[(1S)-1-Phenylethyl]-1,4-dioxa-8-azaspiro[4.5]decane-7-thione . Hydrogen-bond geometry (Å, º)

D—H···A D—H H···A D···A D—H···A
C7—H7A···S1 0.98 2.51 3.019 (3) 112
C16—H16B···S1i 0.97 2.85 3.709 (5) 148

Symmetry code: (i) −x+2, y+1/2, −z+3/2.

References

  1. Bolla, G., Mittapalli, S. & Nangia, A. (2014). CrystEngComm, 16, 24–27.
  2. Busschaert, N., Wenzel, M., Light, M. E., Iglesias-Hernández, P., Pérez-Tomás, R. & Gale, P. A. (2011). J. Am. Chem. Soc. 133, 14136–14148. [DOI] [PMC free article] [PubMed]
  3. Chumakov, Yu. M., Samus’, N. M., Bocelli, G., Suponitskii, K. Yu., Tsapkov, V. I. & Gulya, A. P. (2006). Russ. J. Coord. Chem. 32, 14–20.
  4. Das, U., Sakagami, H., Chu, Q., Wang, Q., Kawase, M., Selvakumar, P., Sharma, R. K. & Dimmock, J. R. (2010). Bioorg. Med. Chem. Lett. 20, 912–917. [DOI] [PMC free article] [PubMed]
  5. Davis, F. A., Chao, B. & Rao, A. (2001). Org. Lett. 3, 3169–3171. [DOI] [PubMed]
  6. Fait, J. (1996). XSCANS. Siemens Analytical X-ray Instruments Inc., Madison, Wisconsin, USA.
  7. Groom, C. R. & Allen, F. H. (2014). Angew. Chem. Int. Ed. 53, 662–671. [DOI] [PubMed]
  8. Gupta, P. K., Manral, L., Ganesan, K., Malhotra, R. C. & Sekhar, K. (2010). Patent WO 2009116084 A2.
  9. Krebs, B. & Gattow, G. (1965). Z. Anorg. Allg. Chem. 340, 294–311.
  10. Kuze, N., Funahashi, H., Ogawa, M., Tajiri, H., Ohta, Y., Usami, T., Sakaizumi, T. & Ohashi, O. (1999). J. Mol. Spectrosc. 198, 381–386. [DOI] [PubMed]
  11. Parsons, S., Flack, H. D. & Wagner, T. (2013). Acta Cryst. B69, 249–259. [DOI] [PMC free article] [PubMed]
  12. Rajesh, K., Reddy, B. P. & Vijayakumar, V. (2012). Ultrason. Sonochem 19, 522–531. [DOI] [PubMed]
  13. Rajesh, K., Vijayakumar, V., Sarveswari, S., Narasimhamurthy, T. & Tiekink, E. R. T. (2010a). Acta Cryst. E66, o1306–o1307. [DOI] [PMC free article] [PubMed]
  14. Rajesh, K., Vijayakumar, V., Sarveswari, S., Narasimhamurthy, T. & Tiekink, E. R. T. (2010b). Acta Cryst. E66, o1988. [DOI] [PMC free article] [PubMed]
  15. Romero, N., Gnecco, D., Terán, J. & Bernès, S. (2013). Acta Cryst. E69, o408–o409. [DOI] [PMC free article] [PubMed]
  16. Romero, N., Gnecco, D., Terán, J., Juárez, J. & Galindo, A. (2007). J. Sulfur Chem. 28, 239–243.
  17. Sanfilippo, P. J., McNally, J. J., Press, J. B., Fitzpatrick, L. J., Urbanski, M. J., Katz, L. B., Giardino, E., Falotico, R., Salata, J., Moore, J. B. Jr & Miller, W. (1992). J. Med. Chem 35, 4425–4433. [DOI] [PubMed]
  18. Shahani, T., Fun, H.-K., Ragavan, R. V., Vijayakumar, V. & Venkatesh, M. (2010). Acta Cryst. E66, o3233–o3234. [DOI] [PMC free article] [PubMed]
  19. Sheldrick, G. M. (2008). Acta Cryst. A64, 112–122. [DOI] [PubMed]
  20. Sheldrick, G. M. (2015). Acta Cryst. C71, 3–8.
  21. Thirumaran, S., Ramalingam, K., Bocelli, G. & Righi, L. (2009). Polyhedron, 28, 263–268.
  22. Tortolani, D. R. & Poss, M. A. (1999). Org. Lett. 1, 1261–1262.
  23. Vijayakumar, V., Rajesh, K., Suresh, J., Narasimhamurthy, T. & Lakshman, P. L. N. (2010). Acta Cryst. E66, o170. [DOI] [PMC free article] [PubMed]
  24. Weber, G. (1984). J. Inclusion Phenom. 1, 339–347.
  25. Woydt, M., Rademacher, P., Brett, W. A. & Boese, R. (1991). Acta Cryst. C47, 1936–1938.

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Crystal structure: contains datablock(s) I, II, global. DOI: 10.1107/S2056989015017119/xu5868sup1.cif

e-71-01207-sup1.cif (229.4KB, cif)

Structure factors: contains datablock(s) I. DOI: 10.1107/S2056989015017119/xu5868Isup2.hkl

e-71-01207-Isup2.hkl (108.5KB, hkl)

Structure factors: contains datablock(s) II. DOI: 10.1107/S2056989015017119/xu5868IIsup3.hkl

e-71-01207-IIsup3.hkl (210.6KB, hkl)

Supporting information file. DOI: 10.1107/S2056989015017119/xu5868Isup4.cml

Supporting information file. DOI: 10.1107/S2056989015017119/xu5868IIsup5.cml

CCDC references: 1424094, 1424093

Additional supporting information: crystallographic information; 3D view; checkCIF report


Articles from Acta Crystallographica Section E: Crystallographic Communications are provided here courtesy of International Union of Crystallography

RESOURCES